We are live on
!
Find out more
VP
Vitruvian Partners Portfolio holdings
AUM
$112M
1-Year Est. Return
2.02%
This Fund
S&P 500
This Quarter
Est. Return
+10.84%
1 Year Est. Return
+2.02%
3 Year Est. Return
+35.84%
5 Year Est. Return
+18.92%
10 Year Est. Return
–
AUM
$2.4B
AUM Growth
-$56.8M
(-2.3%)
Cap. Flow
-$240M
Cap. Flow
% of AUM
-10.02%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
2
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MaxCyte
MXCT
|
+$50.2M |
| 2 |
WKME
WalkMe Ltd. Ordinary Shares
WKME
|
+$5.15M |
| 3 |
Marqeta
MQ
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Global E Online
GLBE
|
+$296M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 66.45% |
| 2 | Technology | 25.87% |
| 3 | Industrials | 5.99% |
| 4 | Healthcare | 1.7% |
Similar funds
RTM
JE
GW
SPWM
OCA
APFP
FCU
DM
Vitruvian Partners's Q3 2021 Portfolio in Review
As of Q3 2021, Vitruvian Partners held 7 positions worth $2.4B, down 2.3% from $2.45B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Vitruvian Partners withdrew a net $240M in Q3 2021, reducing 1 holding. Its largest reduction was Global E Online, cutting an estimated $296M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 66% of assets, up from 62% a quarter earlier, followed by Technology and Industrials.
Against the trend, Vitruvian Partners opened a new position in MaxCyte worth $40.7M.
- Vitruvian Partners's largest Q3 2021 buy was MaxCyte: 3,330,000 shares worth $40.7M.
- Vitruvian Partners added most to WalkMe Ltd. Ordinary Shares in Q3 2021, an estimated $5.15M increase.
- Vitruvian Partners's biggest Q3 2021 reduction was Global E Online, cutting an estimated $296M.
- Vitruvian Partners's ten largest holdings make up 100% of its $2.4B portfolio in Q3 2021.
- Vitruvian Partners opened 1 new position and closed 0 in Q3 2021.
- Vitruvian Partners's portfolio value fell 2.3% quarter-over-quarter to $2.4B.
Based on Vitruvian Partners's 13F filing for Q3 2021, filed 15 Nov 2021.